We are live on ! Find out more
DA

Dunvegan Associates Portfolio holdings

AUM $85.1M
1-Year Est. Return 2.3%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
-2.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
-$2.39M
Cap. Flow
-$3.06M
Cap. Flow %
-2.58%
Top 10 Hldgs %
49.96%
Holding
224
New
153
Increased
5
Reduced
49
Closed
8

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.01M
2
LNG icon
Cheniere Energy
LNG
+$918K
3
V icon
Visa
V
+$252K
4
CBI
Chicago Bridge & Iron Nv
CBI
+$172K
5
AAPL icon
Apple
AAPL
+$149K

Sector Composition

Rank Sector Weight
1 Energy 20.26%
2 Financials 13.68%
3 Healthcare 11.87%
4 Consumer Staples 10.96%
5 Materials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CERS icon
201
Cerus
CERS
$433M
$2K ﹤0.01%
+500
New +$3.21K
WBD icon
202
Warner Bros
WBD
$65.4B
$2K ﹤0.01%
+49
New +$2.07K
DISCK
203
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$2K ﹤0.01%
+50
New +$1.91K
BWP
204
DELISTED
Boardwalk Pipeline Partners
BWP
$2K ﹤0.01%
+175
New +$3.14K
GDXJ icon
205
VanEck Junior Gold Miners ETF
GDXJ
$7.09B
$1K ﹤0.01%
+30
New +$1.16K
CVA
206
DELISTED
Covanta Holding Corporation
CVA
$1K ﹤0.01%
+40
New +$707
GXP
207
DELISTED
Great Plains Energy Incorporated
GXP
$1K ﹤0.01%
+32
New +$811
LVNTA
208
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$1K ﹤0.01%
+24
New +$763
BHI
209
DELISTED
Baker Hughes
BHI
$1K ﹤0.01%
+10
New +$592
STRZA
210
DELISTED
Starz - Series A
STRZA
$1K ﹤0.01%
+34
New +$1.03K
GEB.CL
211
DELISTED
General Electric Capital Corp
GEB.CL
-51,330
Closed -$1.05M
SCHW.PRB.CL
212
DELISTED
The Charles Schwab Corporation
SCHW.PRB.CL
-34,325
Closed -$755K
AGN
213
DELISTED
Allergan Inc
AGN
-34,498
Closed -$3.83M

Similar funds

Dunvegan Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Dunvegan Associates held 224 positions worth $119M, down 2% from $121M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Dunvegan Associates's Q1 2014 filing shows 153 new, 5 increased, 49 reduced and 8 closed positions. Its largest new stake was Allergan plc: 30,358 shares worth $3.77M. The largest sale was Allergan Inc, an estimated $3.83M.

By sector, the portfolio is most concentrated in Energy at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Dunvegan Associates's largest Q1 2014 buy was Allergan plc: 30,358 shares worth $3.77M.
  • Dunvegan Associates added most to Cheniere Energy in Q1 2014, an estimated $918K increase.
  • Dunvegan Associates's biggest Q1 2014 reduction was SPDR Gold Trust, cutting an estimated $1.84M.
  • Dunvegan Associates fully exited Allergan Inc in Q1 2014, selling an estimated $3.83M.
  • Dunvegan Associates's ten largest holdings make up 50% of its $119M portfolio in Q1 2014.
  • Dunvegan Associates opened 153 new positions and closed 8 in Q1 2014.
  • Dunvegan Associates's portfolio value fell 2% quarter-over-quarter to $119M.

Based on Dunvegan Associates's 13F filing for Q1 2014, filed 28 Apr 2017.